Effects of resveratrol on learning and memory in rats with vascular dementia

Zhang,Yeqing; Li,Yuwang; Wang,Yinxiao; Wang,Gengyin; Mao,Lingqun; Zhang,Danhong; Wang,Jinhua

doi:10.3892/mmr.2019.10723

Effects of resveratrol on learning and memory in rats with vascular dementia

Authors:
- Yeqing Zhang
- Yuwang Li
- Yinxiao Wang
- Gengyin Wang
- Lingqun Mao
- Danhong Zhang
- Jinhua Wang
View Affiliations

Affiliations: Department of Neurology, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang 318000, P.R. China, Department of Neurology, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China, School of Public Health, North China University of Science and Technology, Tangshan, Hebei 063210, P.R. China, School of Basic Medicine, North China University of Science and Technology, Tangshan, Hebei 063210, P.R. China
Published online on: October 2, 2019 https://doi.org/10.3892/mmr.2019.10723
Pages: 4587-4593
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The purpose of the present study was to study the effects of resveratrol on cognitive function in rats with vascular dementia and to investigate the molecular mechanisms of its neuroprotective effects. Forty‑five SD rats were randomly divided into 3 groups: The control group (Con group, n=15), the model group (VD group, n=15) and the resveratrol‑treated VD group (Res group, n=15). The VD rats (the VD group and the Res group) were generated by bilateral common carotid artery occlusion. The rats in the Res group received daily resveratrol treatment intraperitoneally for 4 weeks. Cognitive function was tested using the Morris water maze test. The levels of SOD and MDA (oxidative stress indicators) were detected by ELISA kits. The protein expression of Bax, Bcl‑2 and caspase‑3 was detected by western blotting. Compared with the rats in the Con group, the rats in the VD group exhibited decreased cognitive function, significantly increased hippocampal content of MDA, Bax and caspase‑3 (P<0.05), and significantly reduced hippocampal expression of SOD and Bcl‑2 (P<0.05). Compared with the rats in the VD group, the rats in the Res group exhibited increased cognitive ability, reduced hippocampal content of MDA, Bax and caspase‑3 (P<0.05), and increased hippocampal expression of SOD and Bcl‑2 (P<0.05). Resveratrol treatment significantly improved the spatial learning and memory of the VD rats. The mechanism associated with the neuroprotective effects of resveratrol may be closely related to the inhibition of the apoptosis pathway and oxidative stress injury.

View Figures

View References

1	Roman GC: Facts, myths, and controversies in vascular dementia. J Neurol Sci. 226:49–52. 2004. View Article : Google Scholar : PubMed/NCBI
2	Rockwood K, Wentzel C, Hachinski V, Hogan DB, MacKnight C and McDowell I: Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology. 54:447–451. 2000. View Article : Google Scholar : PubMed/NCBI
3	Levine DA and Langa KM: Vascular cognitive impairment: disease mechanisms and therapeutic implications. Neurotherapeutics. 8:361–373. 2011. View Article : Google Scholar : PubMed/NCBI
4	Villaflores OB, Chen YJ, Chen CP, Yeh JM and Wu TY: Curcuminoids and resveratrol as anti-Alzheimer agents. Taiwan J Obstet Gynecol. 51:515–525. 2012. View Article : Google Scholar : PubMed/NCBI
5	Wood LG, Wark PA and Garg ML: Antioxidant and anti-inflammatory effects of resveratrol in airway disease. Antioxid Redox Signal. 13:1535–1548. 2010. View Article : Google Scholar : PubMed/NCBI
6	Chang CC, Chang CY, Huang JP and Hung LM: Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats. Chin J Physiol. 55:192–201. 2012. View Article : Google Scholar : PubMed/NCBI
7	Richard T, Pawlus AD, Iglésias ML, Pedrot E, Waffo-Teguo P, Mérillon JM and Monti JP: Neuroprotective properties of resveratrol and derivatives. Ann N Y Acad Sci. 1215:103–108. 2011. View Article : Google Scholar : PubMed/NCBI
8	Simão F, Matté A, Breier AC, Kreutz F, Trindade VM, Netto CA and Salbego CG: Resveratrol prevents global cerebral ischemia-induced decrease in lipid content. Neurol Res. 35:59–64. 2013. View Article : Google Scholar : PubMed/NCBI
9	Girbovan C, Morin L and Plamondon H: Repeated resveratrol administration confers lasting protection against neuronal damage but induces dose-related alterations of behavioral impairments after global ischemia. Behav Pharmacol. 23:1–13. 2012. View Article : Google Scholar : PubMed/NCBI
10	Shao AW, Wu HJ, Chen S, Ammar AB, Zhang JM and Hong Y: Resveratrol attenuates early brain injury after subarachnoid hemorrhage through inhibition of NF-kappaB-dependent inflammatory/MMP-9 pathway. CNS Neurosci Ther. 20:182–185. 2014. View Article : Google Scholar : PubMed/NCBI
11	Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Kocak A, Yologlu S and Turkoz Y: Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury. Acta Pharmacol Sin. 27:1317–1325. 2006. View Article : Google Scholar : PubMed/NCBI
12	Li F, Gong Q, Dong H and Shi J: Resveratrol, a neuroprotective supplement for Alzheimer's disease. Cur Des. 18:27–33. 2012.
13	Ma T, Tan MS, Yu JT and Tan L: Resveratrol as a Therapeutic Agent for Alzheimer's Disease. Biomed Res Int. 2014:3505162014. View Article : Google Scholar : PubMed/NCBI
14	Winterbourn CC, Peskin AV and Parsons-Mair HN: Thiol oxidase activity of copper, zinc superoxide dismutase. J Biol Chem. 277:1906–1911. 2002. View Article : Google Scholar : PubMed/NCBI
15	Riahi S, Mohammadi MT, Sobhani V and Soleimany M: Chronic effects of aerobic exercise on gene expression of LOX-1 receptor in the heart of rats fed with high fat diet. Iran J Basic Med Sci. 18:805–812. 2015.PubMed/NCBI
16	Wang G, Fang H, Zhen Y, Xu G, Tian J, Zhang Y, Zhang D, Zhang G, Xu J, Zhang Z, et al: Sulforaphane prevents neuronal apoptosis and memory impairment in diabetic rats. Cell Physiol Biochem. 39:901–907. 2016. View Article : Google Scholar : PubMed/NCBI
17	Román GC: Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci. 203-204:7–10. 2002. View Article : Google Scholar : PubMed/NCBI
18	Jellinger KA: The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol. 113:349–388. 2007. View Article : Google Scholar : PubMed/NCBI
19	Ni J, Ohta H, Matsumoto K and Watanabe H: Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res. 653:231–236. 1994. View Article : Google Scholar : PubMed/NCBI
20	Wang J, Zhang HY and Tang XC: Cholinergic deficiency involved in vascular dementia: Possible mechanism and strategy of treatment. Acta Pharmacol Sin. 30:879–888. 2009. View Article : Google Scholar : PubMed/NCBI
21	Bennett S, Grant MM and Aldred S: Oxidative stress in vascular dementia and Alzheimer's disease: A common pathology. J Alzheimers Dis. 17:245–257. 2009. View Article : Google Scholar : PubMed/NCBI
22	Bhatti JS, Kumar S, Vijayan M, Bhatti GK and Reddy PH: Therapeutic strategies for mitochondrial dysfunction and oxidative stress in age-related metabolic disorders. Prog Mol Biol Transl Sci. 146:13–46. 2017. View Article : Google Scholar : PubMed/NCBI
23	Nagayama T, Lan J, Henshall DC, Chen D, O'Horo C, Simon RP and Chen J: Induction of oxidative DNA damage in the peri-infarct region after permanent focal cerebral ischemia. J Neurochem. 75:1716–1728. 2000. View Article : Google Scholar : PubMed/NCBI
24	Nanetti L, Taffi R, Vignini A, Moroni C, Raffaelli F, Bacchetti T, Silvestrini M, Provinciali L and Mazzanti L: Reactive oxygen species plasmatic levels in ischemic stroke. Mol Cell Biochem. 303:19–25. 2007. View Article : Google Scholar : PubMed/NCBI
25	Raz L, Zhang QG, Zhou CF, Han D, Gulati P, Yang LC, Yang F, Wang RM and Brann DW: Role of Rac1 GTPase in NADPH oxidase activation and cognitive impairment following cerebral ischemia in the rat. PLoS One. 5:e126062010. View Article : Google Scholar : PubMed/NCBI
26	Liu H, Zhao M, Yang S, Gong DR, Chen DZ and Du DY: (2R,3S)-Pinobanksin-3-cinnamate improves cognition and reduces oxidative stress in rats with vascular dementia. J Nat Med. 69:358–365. 2015. View Article : Google Scholar : PubMed/NCBI
27	Ghorbanzadeh V, Mohammadi M, Mohaddes G, Dariushnejad H, Chodari L and Mohammadi S: Protective effect of crocin and voluntary exercise against oxidative stress in the heart of high-fat diet-induced type 2 diabetic rats. Physiol Int. 103:459–468. 2016. View Article : Google Scholar : PubMed/NCBI
28	Gustaw-Rothenberg K, Kowalczuk K and Stryjecka-Zimmer M: Lipids' peroxidation markers in Alzheimer's disease and vascular dementia. Geriatr Gerontol Int. 10:161–166. 2010.PubMed/NCBI
29	Wallin A, Kapaki E, Boban M, Engelborghs S, Hermann DM, Huisa B, Jonsson M, Kramberger MG, Lossi L, Malojcic B and et a1: Biochemical markers in vascular cognitive impairment associated with subcortical small vesseldisease-A consensus report. BMC Neurol. 17:1022017. View Article : Google Scholar : PubMed/NCBI
30	Favaloro B, Allocati N, Graziano V, Di Ilio C and De Laurenzi V: Role of apoptosis in disease. Aging (Albany NY). 4:330–349. 2012. View Article : Google Scholar : PubMed/NCBI
31	Garner TP, Lopez A, Reyna DE, Spitz AZ and Gavathiotis E: Progress in targeting the BCL-2 family of proteins. Curr Opin Chem Biol. 39:133–142. 2017. View Article : Google Scholar : PubMed/NCBI
32	Brown LM, Hanna DT, Khaw SL and Ekert PG: Dysregulation of BCL-2 family proteins by leukemia fusion genes. J Biol Chem. 292:14325–14333. 2017. View Article : Google Scholar : PubMed/NCBI
33	Gustafsson AB and Gottlieb RA: Bcl-2 family members and apoptosis, taken to heart. Am J Physiol Cell Physiol. 292:C45–C51. 2007. View Article : Google Scholar : PubMed/NCBI
34	Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG and Youle RJ: Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 139:1281–1292. 1997. View Article : Google Scholar : PubMed/NCBI
35	Grütter MG: Caspases: Key players in programmed cell death. Curr Opin Struct Biol. 10:649–655. 2000. View Article : Google Scholar : PubMed/NCBI
36	Sun ZK, Ma XR, Jia YJ, Liu YR, Zhang JW and Zhang BA: Effects of resveratrol on apoptosis in a rat model of vascular dementia. Exp Ther Med. 7:843–848. 2014. View Article : Google Scholar : PubMed/NCBI
37	Chang CT, Korivi M, Huang HC, Thiyagarajan V, Lin KY, Huang PJ, Liu JY, Hseu YC and Yang HL: Inhibition of ROS production, autophagy or apoptosis signaling reversed the anticancer properties of Antrodia salmonea in triple-negative breast cancer (MDA-MB-231) cells. Food Chem Toxicol. 103:1–17. 2017. View Article : Google Scholar : PubMed/NCBI
38	Zhang Y, Wang LL, Wu Y, Wang N, Wang SM, Zhang B, Shi CG and Zhang SC: Paeoniflorin attenuates hippocampal damage in a rat model of vascular dementia. Exp Ther Med. 12:3729–3734. 2016. View Article : Google Scholar : PubMed/NCBI